- Telehealth visits
Taron R. Davis, MD
Pediatric Physical Medicine and Rehabilitation- Telehealth visits
Taron R. Davis, MD
Pediatric Physical Medicine and Rehabilitation- Telehealth visits
On this page
About me
Dr. Taron Davis is a pediatric physiatrist, a specialist in physical medicine and rehabilitation for infants, children and adolescents with disabling conditions. He cares for young people with amputations or limb deficiencies, and for those who have issues with physical function resulting from brain or spinal cord injuries, rheumatic disorders, cancer, neurological conditions or musculoskeletal conditions.
Davis earned his medical degree at St. Louis University School of Medicine. He completed a combined residency in pediatrics and physical medicine and rehabilitation at the University of Colorado School of Medicine.
Davis is a member of the American Congress of Rehabilitation Medicine and American Academy of Physical Medicine and Rehabilitation.
Education & training
Board certification
- Brain Injury Medicine, American Board of Physical Medicine and Rehab
- Pediatric Rehabilitation Medicine, American Board of Physical Medicine and Rehab
- Physical Medicine & Rehab, American Board of Physical Medicine and Rehab
- Pediatrics, American Board of Physical Medicine and Rehab
Residency
- Pediatric Rehabilitation, University of Colorado at Denver - GME
Internship
- Pediatrics, University of Colorado at Denver - GME
Degree
- MD, St Louis University School of Medicine
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Conditions
- Neurofibromatosis
- Spina Bifida
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.